Published in Br J Cancer on April 11, 2013
Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. PLoS One (2014) 1.55
Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods. World J Gastroenterol (2014) 0.86
The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects. Int J Clin Oncol (2016) 0.75
Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis. Oncotarget (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Pancreatic cancer. Lancet (2011) 8.54
Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09
REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol (2006) 3.37
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials. Lancet Oncol (2012) 2.92
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol (2008) 2.81
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. Lancet Oncol (2008) 2.46
Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma. Cancer (2009) 1.82
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol (2009) 1.78
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. Oncology (2006) 1.58
New biomarkers and targets in pancreatic cancer and their application to treatment. Nat Rev Gastroenterol Hepatol (2012) 1.57
The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol (2012) 1.46
Systemic treatment of advanced pancreatic cancer. Cancer Treat Rev (2012) 1.38
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. Br J Cancer (2012) 1.07
Advances in biomarker research for pancreatic cancer. Curr Pharm Des (2012) 1.05
Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer. Lung Cancer (2008) 1.03
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer. Br J Cancer (2004) 1.02
CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304. J Thorac Oncol (2012) 1.00
Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer. Clin Cancer Res (2010) 0.96
Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy. BMC Cancer (2012) 0.94
Improved sensitivity of fuzzy logic based tumor marker profiles for diagnosis of pancreatic carcinoma versus benign pancreatic disease. Anticancer Res (2001) 0.81
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol (1996) 6.62
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol (1995) 2.57
Attitudes on immunization: a survey of American chiropractors. J Manipulative Physiol Ther (1995) 2.44
Rapid concentration and purification of polyoma virus and SV40 with polyethylene glycol. Virology (1970) 2.37
Interexaminer reliability of eight evaluative dimensions of lumbar segmental abnormality: Part II. J Manipulative Physiol Ther (1993) 2.32
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology (2004) 2.20
Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 2.10
Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses. J Virol (1985) 2.08
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol (1990) 2.03
Loss of simian virus 40 DNA-RNA hybrids from nitrocellulose membranes; implications for the study of virus--host DNA interactions. Proc Natl Acad Sci U S A (1972) 2.00
Third consensus on medical treatment of metastatic breast cancer. Ann Oncol (2009) 1.96
Enzymatic modification of aminoglycoside antibiotics: a new 6'-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 1.81
[Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol (2008) 1.81
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol (2009) 1.78
Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula. Infect Control Hosp Epidemiol (1989) 1.74
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev (2004) 1.74
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation (1997) 1.70
Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am J Pathol (1982) 1.66
Chromosomal mapping of the mink cell focus-inducing and xenotropic env gene family in the mouse. Proc Natl Acad Sci U S A (1983) 1.65
Effects of ondansetron in the prevention of postoperative nausea and vomiting in children. Anesthesiology (1994) 1.65
Strongly linked current flow in polycrystalline forms of the superconductor MgB2. Nature (2001) 1.64
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) (2006) 1.63
Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem (2000) 1.60
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Flow cytometry: principles and clinical applications in hematology. Clin Chem (2000) 1.54
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro. Proc Natl Acad Sci U S A (1975) 1.52
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res (1997) 1.50
Pain on injection: a double-blind comparison of propofol with lidocaine pretreatment versus propofol formulated with long- and medium-chain triglycerides. Anesth Analg (2004) 1.49
Defective bacteriophage PBSH in Bacillus subtilis. II. Intracellular development of the induced prophage. J Virol (1969) 1.49
A congenital hand deformity: Dupuytren's disease. J Hand Surg Am (2001) 1.48
Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia. Leukemia (2003) 1.45
Efficacy of spinal manipulation for chronic headache: a systematic review. J Manipulative Physiol Ther (2001) 1.45
Comparison of the effects of desflurane and isoflurane anaesthesia on hepatocellular function assessed by alpha glutathione S-transferase. Anaesthesia (1999) 1.44
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44
Advantages of intrathecal nalbuphine, compared with intrathecal morphine, after cesarean delivery: an evaluation of postoperative analgesia and adverse effects. Anesth Analg (2000) 1.43
Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur J Clin Invest (1998) 1.42
CYFRA 21-1. A new marker in lung cancer. Cancer (1993) 1.42
[The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI]. Zentralbl Chir (2010) 1.40
Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon. J Biol Chem (1995) 1.40
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am J Pathol (1994) 1.39
Chronic cocaine administration reversibly increases isoflurane minimum alveolar concentration in sheep. Anesthesiology (1996) 1.39
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Ann Oncol (2007) 1.38
Second consensus on medical treatment of metastatic breast cancer. Ann Oncol (2006) 1.37
[Comparative studies on the teaching of oral pathology]. Dtsch Zahnarztl Z (1976) 1.37
[Is the alcoholic really sober, does the applicant drink, can the pilot still fly? CDT test often fails in reliability!]. MMW Fortschr Med (2000) 1.37
Catecholamine-stimulated ion transport in duck red cells. Gradient effects in electrically neutral [Na + K + 2Cl] Co-transport. J Gen Physiol (1982) 1.36
Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. Breast (2005) 1.35
On the regulation of the initiation of DNA replication in bacteria. Cold Spring Harb Symp Quant Biol (1968) 1.35
The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant (2008) 1.34
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res (2001) 1.33
Reticulum cell neoplasms induced in C57BL/6 mice by cultured virus grown in stromal hematopoietic cell lines. J Natl Cancer Inst (1979) 1.33
Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer (1981) 1.33
Non-thymic malignant lymphomas induced in C57BL/6 mice by cloned dualtropic viruses isolated from hematopoietic stromal cell lines. Eur J Cancer (1980) 1.31
Adherence to yoga and exercise interventions in a 6-month clinical trial. BMC Complement Altern Med (2007) 1.30
Pain, disability, and satisfaction outcomes and predictors of outcomes: a practice-based study of chronic low back pain patients attending primary care and chiropractic physicians. J Manipulative Physiol Ther (2001) 1.30
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol (2001) 1.27
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer. Ann Oncol (2013) 1.26
Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ (1998) 1.26
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin. Anticancer Res (1999) 1.24
Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: synthesis, pharmacodynamics, and pharmacokinetics. J Med Chem (2008) 1.22
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J Exp Med (1992) 1.20
Defective bacteriophage PBSH in Bacillus subtilis. I. Induction, purification, and physical properties of the bacteriophage and its deoxyribonucleic acid. J Virol (1969) 1.18
Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med (2001) 1.17
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? Onkologie (2003) 1.17
Transient virus expression during murine leukemia induction by X-irradiation. J Natl Cancer Inst (1977) 1.17
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib. Ann Oncol (2007) 1.17
Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res (1996) 1.14
p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys (1996) 1.14
Coupling of lithium to sodium transport in human red cells. Nature (1975) 1.14
Bumetanide inhibits (Na + K + 2Cl) co-transport at a chloride site. Am J Physiol (1983) 1.13
Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int (1998) 1.13
Physiology and biophysics of chloride and cation cotransport across cell membranes. Fed Proc (1987) 1.13
Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer (2001) 1.13
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol (2001) 1.13
4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem (1999) 1.12
The Na-K-Cl cotransport protein of shark rectal gland. I. Development of monoclonal antibodies, immunoaffinity purification, and partial biochemical characterization. J Biol Chem (1992) 1.12
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial. Ann Oncol (2007) 1.12
Discrepancies in lipolytic activities induced by beta-adrenoceptor agonists in human and rat adipocytes. Horm Metab Res (1990) 1.12
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest (1994) 1.12
Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol (1997) 1.11
New limits on the drift of fundamental constants from laboratory measurements. Phys Rev Lett (2004) 1.11
Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Kidney Int (2006) 1.11
Evaluation of the GlideScope for tracheal intubation in patients with cervical spine immobilisation by a semi-rigid collar. Anaesthesia (2009) 1.10